• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCoronavirus

Anthony Fauci tones down earlier criticism of U.K.’s Pfizer vaccine approval

By
John Lauerman
John Lauerman
,
Mike Dorning
Mike Dorning
and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
John Lauerman
John Lauerman
,
Mike Dorning
Mike Dorning
and
Bloomberg
Bloomberg
Down Arrow Button Icon
December 3, 2020, 10:17 PM ET

Anthony Fauci, the U.S. Government’s top infectious-disease specialist, slammed the U.K.’s drug regulator, saying that it rushed to clear the COVID-19 vaccine from Pfizer Inc. And BioNTech SE.

The U.K. Watchdog, called the Medicines and Healthcare products Regulatory Agency, said Wednesday that it had approved the Pfizer vaccine. That means the shot will likely be used in Britain before the U.S. And the European Union.

“They’re great, they’re good scientists,” Fauci said in an interview with CBS News, according to a transcript. “But they just took the data from the Pfizer company and instead of scrutinizing it really, really carefully [t]hey said, ‘OK, let’s approve it. That’s it.’”

Subscribe to The Capsule, a weekly brief monitoring advances in health care and biopharma, delivered free to your inbox.

The U.S. Food and Drug Administration has been under fire from President Donald Trump because no COVID vaccines were approved before the election in which he was defeated by President-elect Joe Biden. FDA Commissioner Stephen Hahn and other health officials have said that a careful, transparent approval process is key to ensuring public trust in the vaccine that will be required for a successful immunization campaign.

The U.K. “Kind of ran around the corner of the marathon and joined it in the last mile,” Fauci told CBS. “They really rushed through that approval.”

Fauci later attempted to clarify his comments.

“Our process is one that takes more time than it takes in the U.K.,” Fauci told the BBC, according to a report in the Washington Post. “That’s just the reality. I did not mean to imply any sloppiness even though it came out that way.”

The U.K. Department for Health and Social Care tweeted a clip late on Thursday of MHRA Chief Executive Officer June Raine defending the regulator’s methods by saying a “rolling review” process had enabled it to act quickly to approve the vaccine.

“A rolling review can be used to complete the assessment of a promising medicine or a vaccine in a situation where time is of the essence, in the shortest time possible,” she said. “But, and this is a very important point indeed, that doesn’t mean that any corners have been cut. None, at all.”

About the Authors
By John Lauerman
See full bioRight Arrow Button Icon
By Mike Dorning
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.